Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies.
Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, Critchley HO, Li Y, McKain L, Arjona Ferreira JC, Langenberg AG, Wagman RB, Stewart EA. Al-Hendy A, et al. Among authors: stewart ea. Pain Manag. 2023 Apr;13(4):205-211. doi: 10.2217/pmt-2022-0085. Epub 2023 May 15. Pain Manag. 2023. PMID: 37183454 Review.
Lessons learned from 20 years of preclinical testing in pediatric cancers.
Smith MA, Houghton PJ, Lock RB, Maris JM, Gorlick R, Kurmasheva RT, Li XN, Teicher BA, Chuang JH, Dela Cruz FS, Dyer MA, Kung AL, Lloyd MW, Mossé YP, Stearns TM, Stewart EA, Bult CJ, Erickson SW. Smith MA, et al. Among authors: stewart ea. Pharmacol Ther. 2024 Nov 5;264:108742. doi: 10.1016/j.pharmthera.2024.108742. Online ahead of print. Pharmacol Ther. 2024. PMID: 39510293 Review.
Uterine Fibroids.
Stewart EA, Laughlin-Tommaso SK. Stewart EA, et al. N Engl J Med. 2024 Nov 7;391(18):1721-1733. doi: 10.1056/NEJMcp2309623. N Engl J Med. 2024. PMID: 39504521 Review. No abstract available.
Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials.
Simon JA, Stewart EA, Jewell S, Li M, Snabes MC. Simon JA, et al. Among authors: stewart ea. F S Rep. 2024 Jun 14;5(3):285-295. doi: 10.1016/j.xfre.2024.06.002. eCollection 2024 Sep. F S Rep. 2024. PMID: 39381651 Free PMC article.
267 results